New Zealand markets close in 5 hours 4 minutes

ImmunoPrecise Antibodies Ltd. (IPA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.45+0.45 (+9.00%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
30/04/2021
30/04/2020
30/04/2019
Total revenue
19,002
17,912
14,058
10,926
Cost of revenue
8,558
6,374
6,024
5,632
Gross profit
10,444
11,538
8,034
5,295
Operating expenses
Research development
6,403
1,974
446.28
485.845
Selling general and administrative
16,371
13,339
8,328
8,469
Total operating expenses
24,927
15,714
12,081
11,520
Operating income or loss
-14,483
-4,176
-4,047
-6,225
Interest expense
501
863
1,436
1,319
Total other income/expenses net
-402
-1,238
-82.316
-99.216
Income before tax
-15,491
-5,995
-5,293
-7,613
Income tax expense
1,607
1,345
-345.728
4.788
Income from continuing operations
-17,098
-7,340
-4,947
-7,617
Net income
-17,098
-7,340
-4,947
-7,617
Net income available to common shareholders
-17,098
-7,340
-4,947
-7,617
Basic EPS
-
-0.45
-0.35
-0.60
Diluted EPS
-
-0.45
-0.35
-0.60
Basic average shares
-
16,474
13,629
12,542
Diluted average shares
-
16,474
13,629
12,542
EBITDA
-
-1,419
-448.577
-4,031